Stock Split: BrainsWay Ltd. (NASDAQ:BWAY) is set to undergo a stock split on March 3, 2026, aiming to make shares more accessible to a wider range of investors.Strategic Equity Financing: BWAY has entered into a strategic equity financing agreement with BrainStim Health Inc., investing up to $2.5 million to expand its presence in the North American mental health sector.Improved TMS Therapy Access: Evernorth Behavioral Health, part of the Cigna Group, will enhance patient access to TMS therapy by eliminating ...

BURLINGTON, Mass. and JERUSALEM, Feb. 18, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive brain stimulation technologies, today commented on the recent news issued by Evernorth® Behavioral Health, Inc., a division of the Cigna Group, which serves over 18 million covered lives across 12 states, that it will no longer require prior authorization for transcranial magnetic stimulation (TMS) for contracted providers whose patie ...

Core Insights - UnitedHealth Group Incorporated (NYSE:UNH) is recognized as a Dividend Contender, being listed among the top 20 stocks in this category [1] Group 1: Strategic Moves and Industry Implications - Baird analyst Michael Ha described UnitedHealth's decision to rebate profits from its Affordable Care Act (ACA) business as a "potentially masterful move," indicating that this action is not expected to materially impact UNH's earnings for 2026 [2] - The strategic implications of this rebate could pressure competitors who rely more heavily on ACA exchange profitability, particularly companies like Centene (CNC), Molina Healthcare (MOH), and Oscar Health (OSCR) [3] - UnitedHealth plans to provide rebates to its Obamacare plan members in 2026, with CEO Stephen Hemsley confirming collaboration with the Trump administration on rebate structuring [4] Group 2: Market Position and Enrollment Expectations - For the 2026 plan year, UnitedHealthcare will offer ACA marketplace plans across 30 states, although management anticipates a significant decline in ACA enrollment, estimating a potential drop of about two-thirds [5] - UnitedHealth Group operates as a large, diversified global healthcare company, with two primary segments: UnitedHealthcare, which provides health insurance coverage, and Optum, which focuses on technology-driven health services and pharmacy benefits [6]

Core Insights - The article discusses President Trump's unveiling of "The Great Healthcare Plan," which aims to reform the medical pricing structure by targeting kickbacks from pharmacy benefit managers (PBMs) [1][2]. Group 1: Healthcare Plan Overview - The plan seeks to reduce drug prices and insurance premiums by eliminating kickbacks paid by PBMs to large brokerage middlemen, which are seen as predatory fees that inflate costs for patients [2]. - The White House claims that these kickbacks "deceptively raise the cost of health insurance" and intends to redirect subsidies from large insurance companies to eligible Americans directly [2][3]. Group 2: Expert Validation - Independent analysis supports the administration's view on the PBM issue, with experts describing the PBM model as a "pay for play" system that prioritizes rebates over patient efficacy [4]. - Experts suggest that drug manufacturers would price their products significantly lower—up to five times less—if PBMs were removed from the pricing equation [5]. Group 3: Transparency and Accountability - The plan includes a "Plain-English Insurance" standard, requiring insurers to provide clear rate and coverage comparisons without complex jargon, addressing concerns about undefined terms that facilitate claim denials [6]. - The administration's push for "unprecedented accountability" indicates a potential confrontation with the healthcare lobby [6]. Group 4: Investment Opportunities - A list of top PBM operators and pharmaceutical ETFs is provided for investors considering opportunities in light of the ongoing healthcare reform discussions [7]. - Performance data for various stocks and ETFs is included, showing year-to-date and one-year performance metrics for companies like CVS Health Corp., Cigna Group, and UnitedHealth Group, as well as several pharmaceutical ETFs [8][9].

Core Insights - The article discusses former Transportation Secretary Pete Buttigieg's criticism of President Trump's attacks on air traffic controllers, framing them as a distraction from rising health insurance costs and the administration's failures in managing everyday life expenses [1][3]. Group 1: Health Insurance Costs - Buttigieg highlights the economic pressure on Americans due to rising health insurance costs, labeling any deal that does not address these issues as a "bad deal" [2]. - Proposed changes to the Affordable Care Act (ACA) are projected to increase health insurance premiums by up to 10% by 2026, according to the Congressional Budget Office [2]. - The ongoing ACA open enrollment period is critical, with experts warning that it is "too late" to implement proposed subsidy changes without causing significant disruption and confusion among consumers [4]. Group 2: Market Performance of Health Insurers - The article provides a performance overview of several health insurance companies, indicating significant year-to-date and one-year performance declines for some, such as UnitedHealth Group Inc. (-36.26% YTD, -48.57% one year) and Centene Corp. (-43.40% YTD, -43.62% one year) [5]. - In contrast, CVS Health Corp. shows strong performance with a 75.35% increase YTD and 38.94% over one year [5]. - The mixed futures of major indices like S&P 500, Nasdaq 100, and Dow Jones suggest a volatile market environment amid these developments [5].

Cigna Group logged higher profit and revenue in the third quarter, boosted by continued strength in its pharmacy-benefit business Evernorth https://t.co/HBKrG23pOQ ...